Evidence map›Paper›PMID 25415421›Full record

ReviewCurrent opinion in HIV and AIDS2015

How does the timing of antiretroviral therapy initiation in acute infection affect HIV reservoirs?

Jintanat Ananworanich, Karine Dubé, Nicolas Chomont

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in HIV and AIDS, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed, 1 pooled it
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 1 synthesis or guideline pooled it, 116 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Significance of initiating antiretroviral therapy in the early stage of HIV infection.Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2022
    Article
  20. Article

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Jintanat AnanworanichaU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring bHenry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland cThe University of North Carolina, Chapel Hill, North Carolina dVaccine and Gene Therapy Institute Florida, Port St Lucie, Florida, USA.
Karine Dubé
Nicolas Chomont
University of North Carolina at Chapel Hill · USVaccine & Gene Therapy Institute of Florida · USWalter Reed Army Institute of Research · US

Funding

Using NK Cells to eliminate the latent HIV reservoirU19AI096113 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LUCIW, PAUL · 2011 to 2015
$39.5M
Zonisamide in Patients with Neuropathic Pain Associated with Diabetic NeuropathyM01RR000046 · NCRR · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JOY, MELANIE S · 1985 to 2008
$38.5M
Viral reservoirs and sanctuaries in HAART - treated patients: role and mechanismsU19AI096109 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SCHACKER, TIMOTHY W · 2011 to 2015
$29.5M
The Latent HIV Reservoir in Early-treated Thai ChildrenR01AI114236 · NIAID · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI PUTHANAKIT, THANYAWEE, ROBB, MERLIN L · 2014 to 2018
$2.8M
TILDA: A new sensitive and precise assay to measure the size of the latent HIV reservoirR21AI113096 · NIAID · VGTI FLORIDA · PI CHOMONT, NICOLAS · 2014 to 2015
$334k
NCRR NIH HHS M01 RR000046NIAID NIH HHS 1R21 AI113096-01NIAID NIH HHS 1U19AI096109NIAID NIH HHS R01 AI114236NIAID NIH HHS R21 AI113096NIAID NIH HHS U19 AI096109NIAID NIH HHS U19 AI096113NIAID NIH HHS U19AI096113NICHD NIH HHS R01HD080435-01
6 · The paper itself

Abstract

purpose of reviewThe long-lived viral reservoir is a major obstacle to achieving a cure for HIV. Therapeutic strategies, such as early antiretroviral therapy (ART), may be a prerequisite to achieving long-term control of viral replication upon ART withdrawal. RECENT

findingsHIV persistence is established early in acute HIV infection (AHI) with infection in long-lived memory CD4⁺ T cells. Studies conducted in nonhuman primates have suggested that this could occur as early as 3 days postinfection; however, the timing in humans is uncertain. ART during AHI significantly restricts the HIV reservoirs as compared with later treatment. Early ART, particularly prior to the detection of HIV immunoglobulin M, may also reduce the contribution of the long-lived central memory CD4⁺ T cells to the total HIV reservoir, a profile observed in individuals who naturally control HIV without ART. SUMMARY: It is clear that early ART has a greater impact in limiting the HIV reservoirs than later treatment. However, latently infected long-lived memory CD4⁺ T cells persist in most early treated individuals. Therefore, additional interventions will likely be required to eliminate all cells capable of producing replication-competent virus but treatment in AHI may be the critical first step in containing the HIV reservoirs.

Indexed as

HIV-1Acute DiseaseAnti-Retroviral AgentsDisease ReservoirsDrug Administration ScheduleHIV InfectionsHumansViral LoadAnti-Retroviral Agents

Identifiers

PMID25415421
PMCPMC4271317
OpenAlexW1966916498

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.